Eyestem files for IND approval for its product to treat Geographic Atrophy, the largest cause of incurable blindness in the world for people over 50 Learn More
Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors Learn More
Eyestem raises Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya Learn More
Eyestem Research moves one step closer in finding a treatment for Dry AMD and announces successful animal experiments for its flagship product. Learn More
Eyestem announces award of its US patent for creation of Retinal Pigment Epithelium, Photoreceptors and Retinal Organoids Learn More
